Task force: nontraditional markers add little to heart risk assessment.
Mitka
Mike
M
D026683:Advisory Committees; D000572:American Heart Association; D055109:Ankle Brachial Index; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D002097:C-Reactive Protein / Q000378:metabolism; D002339:Carotid Arteries / Q000473:pathology; D003327:Coronary Disease / Q000097:blood* / Q000175:diagnosis* / Q000473:pathology / Q000503:physiopathology; D003331:Coronary Vessels / Q000473:pathology; D006710:Homocysteine / Q000097:blood; D006801:Humans; D007958:Leukocyte Count; D017270:Lipoprotein(a) / Q000097:blood; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012955:Societies, Medical; D014481:United States
D015415:Biomarkers; D001786:Blood Glucose; D017270:Lipoprotein(a); D006710:Homocysteine; D002097:C-Reactive Protein